Oracle: A Turnaround Is Not Imminent (Downgrade) (NYSE:ORCL)
Oracle: A Turnaround Is Not Imminent (Downgrade) (NYSE:ORCL) Seeking Alpha
Covered in this story
Analyst targets on Oracle Corporation
- Wells Fargo: $126 → $250 by Oct 2027 · Overweight via Investing.com UK
- Goldman Sachs: $126 → $206 by Oct 2027 · Buy via TipRanks
- Citizens JMP: $142 → $285 by Oct 2027 via GuruFocus
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $ORCL yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Oracle Corporation →Dalsna Finance is currently tracking 46 stories mentioning Oracle Corporation, the earliest published 10 Mar 2026.
Summary aggregated from Seeking Alpha's public RSS feed. The full reporting belongs to Seeking Alpha — please read it on their site.